Smokers with substance use disorders (SUDs) who quit cigarettes were more likely to report recovery from their other ...

As the U.S. awaits the release of the second report from the Trump administration's Make America Healthy Again (MAHA) ...

In this retrospective study, patients who started a GLP-1 agonist experienced significant declines in hidradenitis ...

Infants up to 6 weeks old with genetically diagnosed presymptomatic spinal muscular atrophy (SMA) treated with oral risdiplam ...

Among 200 patients, the probability of a more desirable day-70 outcome with two doses of intravenous dalbavancin versus 4 to ...

Government-run medical centers serving the nation's veterans have reported an increase in severe staffing shortages, with ...

An off-the-shelf cancer vaccine that targets KRAS mutations induced T-cell responses and was associated with impressive ...

Texas Attorney General Ken Paxton said the state is suing Eli Lilly for allegedly bribing clinicians to prescribe its GLP-1 ...

DermaRite Industries is recalling certain lots of its over-the-counter soaps, antiseptics, and analgesics due to ...

A shorter course of prophylactic antibiotics, or even no course at all, appeared to be noninferior to longer courses in ...

Early drug treatment for ADHD in Sweden was tied to reduced risk of suicidal behavior, substance misuse, transport accidents, and crime. Benefits extended to recurrent events, possibly due to improved ...

The FDA granted fast track designation to a preservative-free intravenous ketamine for the treatment of suicidal ideation and depression, said NRx Pharmaceuticals. Synthetic opioids called nitazenes, ...